Full Fed. Circ. Asked To Restore Apotex Patent
Apotex Inc. has petitioned the Federal Circuit for an en banc rehearing on its decision to invalidate a high blood pressure drug patent, saying Apotex's founder didn't have to reveal prior...To view the full article, register now.
Already a subscriber? Click here to view full article